Heather Beck
Family · Neenah, WINPI 1437343761
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,390 of the $4,151 with a category attached, or 81.7%. It is spread thinly across 29 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,241, 3.0 times the $420 reported in 2021. Among family clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $46.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$515
- Ferring Pharmaceuticals Inc.$502
- Bayer$445
- Johnson & Johnson$396
- Dendreon Pharmaceuticals LLC$251
- Medtronic$218
- plus $2K from 23 others
What the payments were for
- Consulting fees$3879%
- Food & beverage$3,39082%
- Education$3749%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $515 |
| Ferring Pharmaceuticals Inc. | 3 | $502 |
| Bayer | 7 | $445 |
| Johnson & Johnson | 8 | $396 |
| Dendreon Pharmaceuticals LLC | 5 | $251 |
| Medtronic | 6 | $218 |
| Sumitomo Pharma America, Inc. | 7 | $211 |
| Pfizer | 6 | $210 |
| Urogen Pharma, Inc. | 3 | $186 |
| AbbVie(2 entities) | 7 | $178 |
| Accord Healthcare, Inc. | 3 | $167 |
| Intuitive Surgical | 1 | $134 |
| Immunitybio, Inc. | 2 | $121 |
| Teleflex LLC | 1 | $119 |
| Merck | 5 | $97 |
| AstraZeneca | 2 | $74 |
| Myovant Sciences Inc. | 2 | $43 |
| Olympus America Inc. | 2 | $35 |
| Coloplast | 2 | $32 |
| Boston Scientific | 1 | $28 |
| 180 Medical, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $24 |
| Palette Life Sciences, Inc. | 1 | $24 |
| Novartis | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Vertex | 1 | $20 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| Amgen | 1 | $19 |
| Axonics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADSTILADRIN$387
- Erleada$255
- Nubeqa$219
- CAMCEVI$137
- JELMYTO$136
- Da Vinci Surgical System$134
- PROVENGE$132
- UroLift System$119
- Xofigo$107
- ANKTIVA$104
How this compares
$4,151 in reported general payments places this provider in the 95th percentile of 1,273 family providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 19 | $267,966 |
| ErleadaApalutamide | 13 | $188,440 |
| MyrbetriqMirabegron | 215 | $146,261 |
| OrgovyxRelugolix | 38 | $95,670 |
| GemtesaVibegron | 79 | $63,915 |
| Abiraterone Acetate | 17 | $58,713 |
| Tamsulosin Hcl | 745 | $14,534 |
| Mirabegron ErMirabegron | 15 | $5,209 |
| Trospium Chloride ErTrospium Chloride | 18 | $4,605 |
| Finasteride | 257 | $2,905 |
| Methenamine Hippurate | 34 | $2,590 |
| Tolterodine Tartrate ErTolterodine Tartrate | 15 | $2,165 |
| Solifenacin Succinate | 65 | $1,881 |
| Trospium Chloride | 32 | $1,694 |
| Oxybutynin Chloride ErOxybutynin Chloride | 67 | $1,690 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $515 | $414,226234 claims |
| Johnson & JohnsonErleada | $396 | $188,44013 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $211 | $159,586117 claims |
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $20 | $58,71317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,273 family providers in Wisconsin.
Other family in Neenah
- Jaime VelieNeenah$9K
- Stephanie OffordMilwaukee$116K
- Laura SwobodaMenomonee Falls$111K
- Lonniel BainMadison$54K
- Linda WespGlendale$44K
- Andrea BuxtonGreen Bay$36K
- Jani CookGreen Bay$31K
- Tiffany HolleySheboygan$26K
- Kathryn SweetmanMenomonee Falls$26K
- Tracy NelsonMilwaukee$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.